Taylor Morrison Home (TMHC) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
22 Apr, 2026Executive summary
Delivered 2,268 homes at an average price of $578,000, generating $1.3 billion in home closings revenue, with adjusted gross margin of 20.6% and adjusted EPS of $1.12; reported EPS was $1.01.
Net sales orders totaled 2,914, down 14% year-over-year, and backlog increased 23% sequentially to 3,465 homes valued at $2.3 billion.
Liquidity remained strong at $1.6 billion, with book value per share up to $64.06.
Share repurchases totaled $150 million in Q1, with $863 million remaining under authorization expiring December 2027.
Technology and AI investments improved efficiency and customer satisfaction, with over a dozen AI-powered applications in production.
Financial highlights
Home closings revenue was $1.3 billion, down from $1.8 billion year-over-year, with adjusted gross margin at 20.6% and reported gross margin at 20.0%.
SG&A expense was $149 million (11.4% of revenue), up from 9.7% a year ago, but down 16% in dollar terms.
Net homebuilding debt-to-capital ratio was 20.5%.
EBITDA was $163 million; adjusted EBITDA was $183 million.
Mortgage capture rate was 88%, with average buyer FICO score of 750 and 20% downpayment.
Outlook and guidance
Reaffirmed full-year 2026 guidance: ~11,000 home closings at $580,000–$590,000 average price, SG&A ratio in mid-10% range, and effective tax rate of ~25%.
Q2 2026 guidance: 2,500–2,600 closings at ~$575,000 average price, gross margin at least 20%.
Gradual margin improvement expected in the second half, with $2 billion planned land investment and $400 million in share repurchases targeted for 2026.
Active community count expected to rise to 365–370 for the year.
Company focused on managing incentives, controlling costs, and maintaining liquidity amid macroeconomic headwinds.
Latest events from Taylor Morrison Home
- Board recommends approval of all proposals, highlighting governance, pay-for-performance, and ESG.TMHC
Proxy filing10 Apr 2026 - Director elections, executive pay, and auditor ratification up for vote at 2026 annual meeting.TMHC
Proxy filing10 Apr 2026 - 2025 delivered strong earnings and margins; 2026 outlook expects margin recovery and robust capital returns.TMHC
Q4 202511 Feb 2026 - Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20255 Feb 2026 - Targeting 20,000 closings by 2028 with digital innovation, margin focus, and brand expansion.TMHC
Investor Day 20253 Feb 2026 - Q2 2024 delivered 3,200 closings, $1.99B revenue, and raised full-year guidance.TMHC
Q2 20243 Feb 2026 - Q3 net income up 54% to $251M, with record revenue, margin gains, and strong outlook.TMHC
Q3 202419 Jan 2026 - Double-digit growth in closings and revenue, with strong margins and 2025 outlook.TMHC
Q4 202411 Dec 2025 - Board recommends approval of all proposals, emphasizing governance, pay-for-performance, and ESG.TMHC
Proxy Filing1 Dec 2025